AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Modalis Therapeutics Corporation
  3. Financials
  4. Free cash flow

Modalis Therapeutics Corporation【JP:4883】

Market cap
¥4.3B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndFree cash flow (Million JPY)YoY (%)
Dec 31, 2025-2,121+48.09%
Dec 31, 2024-1,432-37.57%
Dec 31, 2023-2,294+9.61%
Dec 31, 2022-2,093+144.92%
Dec 31, 2021-855+118.16%
Dec 31, 2020-392-330.61%
Dec 31, 2019170

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)